The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Would be good if PYC gets involved with this.
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
https://www.icr.ac.uk/news-archive/immune-cells-hunt-down-cancer-around-the-body-discovery-could-lead-to-personalised-treatments-for-advanced-breast-cancer
Pyc attending this (Hopefully getting 15% discount of the $3550 fee now they’re member).
https://www.physiomics.co.uk/bio-2024/
Physiomics now a member. ( Think they had to pay for this)
https://x.com/physiomics/status/1787824338835542193?s=61&t=0G9XeE3tHfuoBf1VEsPycQ
Link to Biotrinity.
https://twitter.com/hashtag/BioTrinity?src=hashtag_click
Also attending this next week.
https://www.physiomics.co.uk/biotrinity-2024/
Physiomics attending next week.
https://www.physiomics.co.uk/oxford-global-immuno-2024/
Pyc announced contract with Sheffield Uni etc in February, BBC announced following.
More than £2.5m will be ploughed into new research into blood cancer in Sheffield, it has been announced.
The University of Sheffield was given the funding to look into dormant cancer cells and develop new treatments for myeloma, a type of blood cancer.
https://x.com/physiomics/status/1780186840005259327?s=61&t=0G9XeE3tHfuoBf1VEsPycQ
My instinct is telling me that they will take back Fernando Ortega (who was their senior PK/PD Modeller for several years ) for this role.
He had involvement with Dr Hitesh Mistry on a number of projects.
I think he left as his potential wasn’t being used as it should, now with this position he could be enticed back.
These are just my way of thinking, as usual I could be entirely wrong.
From their RNS March 2nd 2022.
Physiomics will be supporting Ankyra with modelling and simulation of ANK-101 in immune-oncology settings in support of its early development.
https://www.physiomics.co.uk/contract-award-9/
Pyc reposted this about a licensing deal between Ankyra and Jenga Bioscience with their platform JEN-101 (formerly cANK-101 (PYC helped developed.)).
https://www.linkedin.com/posts/ankyratx_ankyra-therapeutics-and-jenga-biosciences-activity-7178508921270079488-WtE0?utm_source=share&utm_medium=member_desktop
Interesting.
Dose me posted on twitter on 18th March, Pyc retweeted mentioning they still working with Doseme. I’m awaiting outcome of this.
https://x.com/Physiomics/status/1772939227359007009?s=20
https://x.com/Physiomics/status/1772939225266065552?s=20
Looks like not much interest if they have to put a tweet out at 11:45 informing their presence there.
https://x.com/physiomics/status/1767879752117797059?s=61&t=0G9XeE3tHfuoBf1VEsPycQ
If unable to open previous link.
https://www.physiomics.co.uk/about/careers/
Dr Hitesh Mistry is currently named in that position, has he finally parted ways with Physiomics?
Doesn’t seem much confidence with a positive result tomorrow.
Meanwhile, new post being advertised “Principle Consultant”.
https://uk.linkedin.com/jobs/view/principal-consultant-head-of-modelling-at-physiomics-plc-3848190072
Strange, not sure if PYC has did this in the past when Interims posted.
https://x.com/InvestorMeetCo/status/1763589672016449891?s=20
This week we had following low trades.
Mon 61
Tue 31
Wed 33
Thur 33
Fri. 33
Next week maybe RNS for Interims, will this have an effect on SP?
Will there be another RNS?
Posted today. What I posted on 14th Feb.
https://www.linkedin.com/posts/physiomics-plc_national-research-council-of-canada-announces-activity-7166464012954619904-yl-u?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy
Some info on 2 of the women scientists at Physiomics.
https://www.physiomics.co.uk/celebrating-international-day-of-women-and-girls-in-science-with-the-brilliant-women-at-physiomics/